Edesa Biotech, Inc.
EDSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001540159
No open-market purchases or sales by Edesa Biotech, Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $30.0M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Edesa Biotech, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 17 | 1 | 20 | +4 |
| Shares | 207.5K | 25 | 2.82M | +2.61M (+1,260.3%) |
| Value | $350.1K | $42 | $6.89M | +$6.54M (+1,867.0%) |
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (7)
Institutions that held Edesa Biotech, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Stonepine Capital Management, LLC | 687,500 | $1.68M | 1.95% |
| Rubric Capital Management LP | 687,500 | $1.68M | 0.03% |
| Velan Capital Investment Management LP | 687,500 | $1.68M | 1.73% |
| Nantahala Capital Management, LLC | 625,000 | $1.52M | 0.13% |
| Commonwealth Equity Services, LLC | 50,003 | $122.0K | 0.00% |
| CIBC World Markets Inc. | 19,999 | $48.8K | 0.00% |
| Avion Wealth | 242 | $0 | 0.00% |
Sold out (3)
Institutions that held Edesa Biotech, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| CM Management, LLC | 110,000 | $184.8K |
| Two Sigma Securities, LLC | 15,313 | $25.7K |
| Morgan Stanley | 14 | $24 |
Not filed for Q1 2025 yet (1)
Institutions that held Edesa Biotech, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Global Retirement Partners, LLC | 25 | $42 |